Theravance Biopharma (TBPH) Asset Utilization Ratio (2014 - 2026)

Theravance Biopharma (TBPH) has reported Asset Utilization Ratio for 13 consecutive years, with 0.23 the latest figure, recorded in Q1 2026.

• In Q1 2026, Asset Utilization Ratio rose 22.52% year-over-year to 0.23; the TTM figure through Mar 2026 stood at 0.23 (up 22.52% YoY), while the FY2025 annual figure was 0.02, down 89.79% from the prior year.
• Asset Utilization Ratio eased to 0.23 in Q1 2026 per TBPH's latest filing, from 0.24 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.24 in Q4 2025 and bottomed at 0.07 in Q4 2022.
• Historically, Asset Utilization Ratio has averaged 0.16 across 5 years, with a median of 0.16 in 2024.
• Annual changes were most pronounced in 2022 — Asset Utilization Ratio slumped 47.32% — and 2023, when it surged 92.71%.
• Theravance Biopharma's Asset Utilization Ratio stood at 0.07 in 2022, then soared by 92.71% to 0.14 in 2023, then advanced by 25.58% to 0.18 in 2024, then soared by 31.58% to 0.24 in 2025, then dropped by 3.91% to 0.23 in 2026.
• Business Quant data shows TBPH's Asset Utilization Ratio at 0.23 in Q1 2026, 0.24 in Q4 2025, and 0.19 in Q3 2025.